Compare DexCom, Inc. (DXCM) vs Southern Copper Corp (SCCO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DexCom, Inc. vs Southern Copper Corp — how do they compare? DexCom, Inc. trades at $72.58 (market cap $28.06B), while Southern Copper Corp trades at $181.54 (market cap $151.46B). The key difference: Southern Copper Corp is far larger — about 5.4× DexCom, Inc.'s market cap, and Southern Copper Corp pays a 2.2% dividend while DexCom, Inc. pays none. Which is the better fit depends on your goals.
| DXCM | SCCO | |
|---|---|---|
Market Cap | $28.06B | $151.46B |
Sector | Health | Basic Materials |
52-Week High | $89.53 | $218.85 |
52-Week Low | $54.84 | $90.54 |
Enterprise Value | $27.03B | $153.52B |
Dividend Yield | — | 2.2% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DXCM trades at $77.31, up 4.3% on the day, with a bullish technical outlook as it approaches resistance near $78. The company reported strong earnings beats in recent quarters, with Q1 2026 EPS of $0.56 surpassing expectations of $0.47. Revenue growth accelerated to $4.66 billion in 2025, while net income margin expanded to 17.93%. Recent regulatory approvals, including Health Canada authorization for the G7 15-day CGM, support continued international expansion.
The stock offers growth potential with analyst consensus price target of $84.33, though high valuation multiples (P/E 31.21) and competition in the CGM market present risks. Expansion into non-insulin Type 2 diabetes and pediatric markets could drive future revenue, but commercial uptake remains unproven. Institutional sentiment remains strongly bullish with 80% buy ratings.
SCCO trades at $175.9, down 3.55% today, with a bullish technical signal from moving averages and neutral oscillators. The company reported strong earnings beats in recent quarters, with Q1 2026 EPS of $1.90 exceeding the $1.82 estimate. Revenue grew to $13.42 billion in 2025, and net income margin expanded to 34.13%. A $1.00 dividend was declared for H1 2026, payable on May 29, 2026.
Outlook remains positive due to robust profitability and growth, but high valuation ratios (P/E 30.73, P/S 10.51) and mixed analyst sentiment pose risks. Copper demand from AI and electrification trends supports long-term prospects, yet price volatility and economic cycles are key concerns for investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About DexCom, Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →About Southern Copper Corp
Southern Copper Corp is an integrated producer of copper and other minerals and operates the mining, smelting, and refining facilities in Peru and Mexico. Its production includes copper, molybdenum, zinc, and silver. The company operates through the following segments: Peruvian operations, Mexican open-pit operations, and Mexican underground mining operations. Southern Copper generates the majority of its revenue from the sale of copper and the rest from the sale of non-copper products, such as molybdenum, silver, zinc, lead, and gold. Its geographical segments are The Americas, Europe, and Asia.
Read more on SCCO →
